The potential of nanotherapeutics to target brain tumors: current challenges and future opportunities

Nanomedicine (Lond). 2021 Sep;16(21):1833-1837. doi: 10.2217/nnm-2021-0134. Epub 2021 Jul 12.

Authors

Tanem Garanti¹, Mohamed A Alhnan², Ka-Wai Wan³

Affiliations

¹ Faculty of Pharmacy, Cyprus International University, Haspolat, Nicosia, 99258, Cyprus via Mersin 10, Turkey.
² Institute of Pharmaceutical Science, Faculty of Life Sciences & Medicine, King's College London, London, SE1 9NH, UK.
³ School of Pharmacy & Biomedical Sciences, University of Central Lancashire, Preston, Lancashire, PR1 2HE, UK.

PMID: 34251278
DOI: 10.2217/nnm-2021-0134

No abstract available

Keywords: NLC; SLN; brain tumor; glioblastoma; liposome; nanomedicine; polymer nanoparticles; targeted therapy.

Publication types

Editorial

MeSH terms

Brain Neoplasms* / drug therapy
Humans
Nanomedicine
Nanoparticles*